Search Results - "SQUIRE, J. A"

Refine Results
  1. 1

    Pan-cancer genomic analysis shows hemizygous PTEN loss tumors are associated with immune evasion and poor outcome by Vidotto, T., Melo, C. M., Lautert-Dutra, W., Chaves, L. P., Reis, R. B., Squire, J. A.

    Published in Scientific reports (28-03-2023)
    “…In tumors, somatic mutations of the PTEN suppressor gene are associated with advanced disease, chemotherapy resistance, and poor survival. PTEN loss of…”
    Get full text
    Journal Article
  2. 2

    Fish analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome by YOSHIMOTO, M, CUNHA, I. W, COUDRY, R. A, FONSECA, F. P, TORRES, C. H, SOARES, F. A, SQUIRE, J. A

    Published in British journal of cancer (28-08-2007)
    “…This study examines the clinical impact of PTEN genomic deletions using fluorescence in situ hybridisation (FISH) analysis of 107 prostate cancers, with…”
    Get full text
    Journal Article
  3. 3

    Chromosome 6p amplification and cancer progression by Santos, Gda C, Zielenska, M, Prasad, M, Squire, J A

    Published in Journal of Clinical Pathology (01-01-2007)
    “…Chromosomal imbalances represent an important mechanism in cancer progression. A clear association between DNA copy-number aberrations and prognosis has been…”
    Get full text
    Journal Article Book Review
  4. 4

    The Role of RUNX2 in Osteosarcoma Oncogenesis by van Wijnen, A. J., Zielenska, Maria, Stein, Gary S., Squire, Jeremy A., Martin, Jeff W.

    Published in Sarcoma (2011)
    “…Osteosarcoma is an aggressive but ill-understood cancer of bone that predominantly affects adolescents. Its rarity and biological heterogeneity have limited…”
    Get full text
    Journal Article
  5. 5

    Amplification of telomerase ( ) gene is a poor prognostic marker in non-small-cell lung cancer by ZHU, C.-Q, CUTZ, J.-C, LIU, N, LAU, D, SHEPHERD, F. A, SQUIRE, J. A, TSAO, M.-S

    Published in British journal of cancer (22-05-2006)
    “…Telomerase reactivation is a hallmark of human carcinogenesis. Increased telomerase activity may result from gene amplification and/or overexpression. This…”
    Get full text
    Journal Article
  6. 6

    Breast cancer 1 (BRCA1) protein expression as a prognostic marker in sporadic epithelial ovarian carcinoma: an NCIC CTG OV.16 correlative study by Weberpals, J.I., Tu, D., Squire, J.A., Amin, M.S., Islam, S., Pelletier, L.B., O'Brien, A.M., Hoskins, P.J., Eisenhauer, E.A.

    Published in Annals of oncology (01-11-2011)
    “…Breast cancer 1 (BRCA1) protein inactivation in sporadic ovarian carcinoma (OC) is common and low BRCA1 expression is linked with platinum sensitivity. The…”
    Get full text
    Journal Article
  7. 7

    Topographical analysis of telomere length and correlation with genomic instability in whole mount prostatectomies by Joshua, A.M., Shen, E., Yoshimoto, M., Marrano, P., Zielenska, M., Evans, A.J., Van der Kwast, T., Squire, J.A.

    Published in The Prostate (15-05-2011)
    “…BACKGROUND Many critical events in prostatic carcinogenesis appear to relate to the emergence of genomic instability. Characteristic genomic abnormalities such…”
    Get full text
    Journal Article
  8. 8

    Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping by BAYANI, J, ZIELENSKA, M, MARRANO, P, YIM KWAN NG, TAYLOR, M. D, JAY, V, RUTKA, J. T, SQUIRE, J. A

    Published in Journal of neurosurgery (01-09-2000)
    “…Medulloblastomas and related primitive neuroectodermal tumors (PNETs) of the central nervous system are malignant, invasive embryonal tumors with predominantly…”
    Get full text
    Journal Article
  9. 9

    Expression of TEL-JAK2 in Primary Human Hematopoietic Cells Drives Erythropoietin-Independent Erythropoiesis and Induces Myelofibrosis in vivo by Kennedy, J. A., Barabé, F., Patterson, B. J., Bayani, J., Squire, J. A., Barber, D. L., Dick, J. E.

    “…Activation of JAK2 by chromosomal translocation or point mutation is a recurrent event in hematopoietic malignancies, including acute leukemias and…”
    Get full text
    Journal Article
  10. 10

    Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH by Selvarajah, S, Yoshimoto, M, Ludkovski, O, Park, P C, Bayani, J, Thorner, P, Maire, G, Squire, J A, Zielenska, M

    Published in Cytogenetic and genome research (01-01-2008)
    “…Osteosarcoma (OS) is characterized by an unstable karyotype which typically has a heterogeneous pattern of complex chromosomal abnormalities. High-resolution…”
    Get more information
    Journal Article
  11. 11

    Correlating breakage-fusion-bridge events with the overall chromosomal instability and in vitro karyotype evolution in prostate cancer by Vukovic, B, Beheshti, B, Park, P, Lim, G, Bayani, J, Zielenska, M, Squire, J A

    Published in Cytogenetic and genome research (01-01-2007)
    “…Chromosomal instability (CIN) is thought to underlie the generation of chromosomal changes and genomic heterogeneity during prostatic tumorigenesis. The…”
    Get more information
    Journal Article
  12. 12

    Quantitative PCR identifies a minimal deleted region of 120 kb extending from the philadelphia chromosome ABL translocation breakpoint in chronic myeloid leukemia with poor outcome by KOLOMIETZ, E, MARRANO, P, SQUIRE, J. A, YEE, K, THAI, B, BRAUDE, I, KOLOMIETZ, A, CHUN, K, MINKIN, S, KAMEL-REID, S, MINDEN, M

    Published in Leukemia (01-07-2003)
    “…Fluorescence in situ hybridization (FISH) analysis has shown previously that 10-15% of chronic myeloid leukemias (CML) have hemizygous deletions of variable…”
    Get full text
    Journal Article
  13. 13

    A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer by Koti, M, Siu, A, Clément, I, Bidarimath, M, Turashvili, G, Edwards, A, Rahimi, K, Masson, A-M M, Squire, J A

    Published in British journal of cancer (31-03-2015)
    “…Background: Chemotherapy resistance is a major determinant of poor overall survival rates in high-grade serous ovarian cancer (HGSC). We have previously shown…”
    Get full text
    Journal Article
  14. 14

    Cause and Consequences of Genetic and Epigenetic Alterations in Human Cancer by Sadikovic, B, Al-Romaih, K, Squire, J A, Zielenska, M

    Published in Current genomics (01-09-2008)
    “…Both genetic and epigenetic changes contribute to development of human cancer. Oncogenomics has primarily focused on understanding the genetic basis of…”
    Get full text
    Journal Article
  15. 15

    Integrated cytogenetic and high-resolution array CGH analysis of genomic alterations associated with MYCN amplification by Pandita, A, Bayani, J, Paderova, J, Marrano, P, Graham, C, Barrett, M, Prasad, M, Zielenska, M, Squire, J A

    Published in Cytogenetic and genome research (01-04-2011)
    “…Amplification of oncogenes and closely linked flanking genes is common in some types of cancer and can be associated with complex chromosome rearrangements…”
    Get more information
    Journal Article
  16. 16

    Analysis of segmental duplications, mouse genome synteny and recurrent cancer-associated amplicons in human chromosome 6p21-p12 by Martin, J W, Yoshimoto, M, Ludkovski, O, Thorner, P S, Zielenska, M, Squire, J A, Nuin, P A S

    Published in Cytogenetic and genome research (01-06-2010)
    “…It has been proposed that regions of microhomology in the human genome could facilitate genomic rearrangements, copy number transitions, and rapid genomic…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19

    Advances in the detection of chromosomal aberrations using spectral karyotyping by Bayani, J, Squire, JA

    Published in Clinical genetics (01-02-2001)
    “…Spectral karyotyping (SKY) is a powerful 24‐color, whole chromosome‐painting assay allowing the visualization of each chromosome in one experiment. Subtle…”
    Get full text
    Journal Article
  20. 20

    Frequent monoallelic loss of D13S319 in multiple myeloma patients shown by interphase fluorescence in situ hybridization by CHANG, H, BOUMAN, D, BOERKOEL, C. F, STEWART, A. K, SQUIRE, J. A

    Published in Leukemia (1999)
    “…Deletions or monosomy of chromosome 13 are frequent in multiple myeloma (MM). A candidate tumor suppressor gene might reside telomeric of the retinoblastoma…”
    Get full text
    Journal Article